Skip to main content

Table 1 Clinical Characteristics of Patients with post-stenotic aortic dilatation and control group

From: Lymphocyte-to-monocyte ratio associated with severe post-stenotic aortic dilation in a case–control study

 

Post-stenotic aortic dilatation

Control group

p value

Patient population (n)

57

151

 

Demographic data

 Age (years)

60.0 (11.0)

60.0 (12.0)

0.909

 Sex, male (n)

41 (71.9%)

94 (62.3%)

0.174

Medical history

 Hypertension (n)

19 (33.3%)

56 (37.1%)

0.638

 Smoking (n)

31 (54.4%)

63 (41.7%)

0.094

 Diabetes (n)

3 (5.3%)

15 (9.9%)

0.435

 Tricuspid aortic valve (n)

34 (59.6%)

79 (52.3%)

0.321

 Chronic use of glucocorticoid (n)

21 (36.8%)

62 (41.1%)

0.636

Baseline echocardiography

 LVEDD (cm)

6.02 (1.74)

5.45 (1.49)

0.011

 LVEF (%)

57 (7.5)

60 (7)

0.006

Laboratory tests

 Leukocyte (109/L)

6.11 (2.06)

5.89 (1.96)

0.405

 Neutrophil (109/L)

3.48 (1.54)

3.49 (1.51)

0.896

 Platelet (109/L)

178 (75.5)

195.5 (71.5)

0.183

 Monocyte (109/L)

0.59 (0.37)

0.50 (0.24)

0.006

 Lymphocyte (109/L)

1.74 (0.68)

1.84 (0.68)

0.675

 LMR

2.72 (1.62)

3.53 (1.75)

0.002

 LDL-C (mmol/L)

2.78 (1.15)

2.80 (1.19)

0.843

 CRP (mg/L)

0.93 (0.91)

0.91 (1.62)

0.388

 MPV (fl)

10.60 (1.15)

10.90 (1.25)

0.329

  1. The categorical variables in the table are presented by the number of cases (with percentage) and the continuous variables are expressed by the median (with interquartile range) or mean (with standard deviation)
  2. p values were the results of unpaired t-test or Mann–Whitney U test for continuous variables, and χ2 test or Fisher’s exact test for categorical variables
  3. p value: Compare the patients with and without ascending aorta dilatation
  4. LVEDD left ventricular end diastolic diameter, LVEF left ventricular ejection fraction, LMR lymphocyte-to-monocyte ratio, LDL-C low density lipoprotein cholesterol, CRP C-reaction protein, MPV mean platelet volume